Driver Mutations Determine Survival in Smokers and Never-Smokers With Stage IIIB/IV Lung AdenocarcinomasPAIK, Paul K; JOHNSON, Melissa L; D'ANGELO, Sandra P et al.Cancer. 2012, Vol 118, Num 23, pp 5840-5847, issn 0008-543X, 8 p.Article

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant CancersDOGAN, Snjezana; RONGLAI SHEN; LADANYI, Marc et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6169-6177, issn 1078-0432, 9 p.Article

Association of KRAS and EGFR Mutations With Survival in Patients With Advanced Lung AdenocarcinomasJOHNSON, Melissa L; SIMA, Camelia S; CHAFT, Jamie et al.Cancer. 2013, Vol 119, Num 2, pp 356-362, issn 0008-543X, 7 p.Article

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitorsBREVET, Marie; JOHNSON, Melissa L; AZZOLI, Christopher G et al.Lung cancer. 2011, Vol 73, Num 1, pp 96-102, issn 0169-5002, 7 p.Article

Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung AdenocarcinomasD'ANGELO, Sandra P; CATHERINE PIETANZA, M; JOHNSON, Melissa L et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 2066-2070, issn 0732-183X, 5 p.Article